paeonol has been researched along with Neuralgia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, L; Cao, Z; Guo, Q; Huang, Q; Liu, X; Zeng, R | 1 |
| Chang, S; Chen, Z; Gao, L; Jing, B; Li, X; Shi, H; Zhang, D; Zhao, G; Zheng, Y | 1 |
2 other study(ies) available for paeonol and Neuralgia
| Article | Year |
|---|---|
Paeonol inhibits chronic constriction injury-induced astrocytic activation and neuroinflammation in rats via the HDAC/miR-15a pathway.
Topics: Animals; Constriction; Histones; MicroRNAs; Neuralgia; Neuroinflammatory Diseases; Rats; Rats, Sprague-Dawley | 2022 |
Paeonol alleviates neuropathic pain by modulating microglial M1 and M2 polarization via the RhoA/p38MAPK signaling pathway.
Topics: Animals; Lipopolysaccharides; MAP Kinase Signaling System; Microglia; Neuralgia; Rats; Rats, Sprague-Dawley; Spinal Cord Dorsal Horn | 2023 |